Avammune Therapeutics secures undisclosed funding from The Chennai Angels

The Chennai Angels have provided funding to Avammune Therapeutics Inc for the completion of IND enabling studies for their Immuno-oncology asset.

The funding will be used to advance Avammune's assets for cancer and autoimmune illnesses, according to the business.

"We are creating a revolutionary class of medications that harness the body's first line of defense against infections to attack cancer," says Dr. Aditya Kulkarni, Chief Scientific Officer of Avammune. These extremely powerful medications have the ability to overcome drug resistance and, due to their chemical composition, may be administered to patients as oral tablets, making them potentially more cheap alternatives to biological treatments."

Avammune is in active discussions with large pharmaceutical and biotech businesses about collaborating on clinical translation of the assets, as well as with strategic investors about bringing the assets through clinical testing independently.

Arun B Papaiah, CEO, Avammune said, “Avammune’s technology platform has been validated in various animal models and is gearing up for safety studies. With the influx of funding, we are hoping to complete these safety studies and are gearing up for partnerships for entering clinical testing next year. This latest round of funding will also allow us to further strengthen our diversified pipeline of drugs for cancers and autoimmune diseases. It is a pleasure working with The Chennai Angels who join existing and other new investors and are excited to bring them on board as partners.”

Avammune is in advanced talks with large pharmaceutical and biotech businesses about collaborating on clinical translation of the assets, as well as with strategic investors about bringing the assets through clinical testing independently.

According to Sameer Mehta, Director of Mehta's Multispecialty Hospital India Pvt Ltd and Lead Investor from The Chennai Angels, despite remarkable advances in the discovery and development of new cancer therapies, the illness continues to impact millions each year. TCA is excited to be a part of Avammune's Immuno-oncology asset development.

Tags : #fundingalert #avammune #investor #bussiness #studies #smitakumar #medicircle #funding

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

FTCCI with support from the Ministry of MSME, Govt of Inia to host an International Conference on Shipping and Logistics at HICC on 22nd MarchMarch 18, 2024
Rotary donates Upgraded Neonatal ICU at Niloufer Hospital worth Rs 48 LakhsMarch 18, 2024
Fateh Education shares insight into Financial strategies and Post-Study employment goals of students aspiring to study abroadMarch 18, 2024
Empowering Communities: We Care Foundation Hosts 3rd Edition of I - Inspiration Awards, Championing Health, Finance, and Cyber WellnessMarch 18, 2024
Safeguarding Spectators: Medulance Partners with Zomato Live for On-site Medical Assistance at ZomalandMarch 18, 2024
Unsung hero, Chindu Yakshaganam theatre artist, Padma Shri Gaddam Sammaiah graced the 17th Annual Day of Anurag UniversityMarch 18, 2024
Multidisciplinary Approach at Citizens Specialty Hospital Saved 35-year-old Patient with Disc Prolapse following a recent Heart AttackMarch 18, 2024
Asia Pacific region’s First Patellofemoral Joint surgery is successful in India.March 18, 2024
FDA Greenlights Lupin's Varenicline Tablets: A Game-Changer in Smoking Cessation TherapyMarch 18, 2024
Deciphering STAP-1: A Promising Target for Immune-Related DiseasesMarch 18, 2024
The Gut-Brain Connection: How Gut Bacteria Shape Immunity and Prevent Allergic Reactions in NewbornsMarch 18, 2024
IIIT Hyderabad’s Annual R&D Showcase beginsMarch 16, 2024
Exploring New Horizons: The Role of Copper and Resveratrol in Cancer CareMarch 16, 2024
Expanding Healthcare Infrastructure: Delhi’s Ambitious EndeavourMarch 16, 2024
FTCCI's Tourism Committee brands cab drivers as ambassadors for tourism and trains 200 cab drivers at GMR Airport in Etiquette, Hygiene, First Aid, CPR and the English languageMarch 16, 2024
Musing of a Teenage Girl, a poetry book authored by a 14 years girl Sanjana Somavarapu releasedMarch 16, 2024
5th Edition FTCCI HR Awards 2023 Presented for best practices in people processesMarch 15, 2024
FTCCI Delegation visits T-WorksMarch 15, 2024
Debunking Myths: ICMR Study Disproves COVID Vaccine Link to Sudden DeathsMarch 15, 2024
Beware of Rhodamine-B: Several States in India Implement Ban on Artificial Food Coloring AgentsMarch 15, 2024